Phase II Trial of 64Cu-ATSM PET/CT in Cervical Cancer
Protocol-ACRIN 6682 Amendment 3, v3.1.13 [PDF]
SOC-ACRIN 6682 Amendment 3, v3.1.13 [PDF]
Informed Consent-ACRIN 6682 [DOC]
Cu-64 ATSM Investigator's Brochure Version 2.0, 8.24.10 [PDF]
Principal Investigator: Farrokh Dehdashti, MD
Status: In follow-up
Main Objective: The objective of this study is to determine whether 64CU-ATSM
used with PET/CT can distinguish patients with poorer survival outcomes from those
with better survival outcomes prior to initiation of therapy.
Participants: Women with stages IB2–IVA, histologically confirmed, invasive squamous
cell cervical carcinoma, who are scheduled to undergo radiation therapy and concurrent
Study Design Summary: A total of 100 female participants will be enrolled into the study
at a minimum of three (3) institutions.